A comparison of the efficacy of topical adapalene gel 0.1% with tretinoin gel 0.025% in mild acne vulgaris

Mehran Khan, Naimat Ullah Khan, Muhammad Irfan Anwar, Sahibzada Mahmood Noor

Abstract


Objective  To compare the efficacy of topical adapalene with topical tretinoin in the treatment of mild acne  vulgaris .

 

Methods  This randomized controlled trial was conducted over a period of 6 months in outpatient department of dermatology, Lady Reading Hospital, Peshawar. 101 patients were taken after nonprobability consecutive sampling in each group. Topical adapalene 0.1% gel was given to group A while topical tretinoin 0.025% gel was given to group B for once daily application. Efficacy was ascertained after the end of third month and was graded as excellent or poor response. The data were statistically analyzed using SPSS version 11.

 

Results  Out of 202 patients, male and female patients were 91 and 111, respectively with male to female ratio 0.8:1. The age of the patients ranged from 15-25 years. Mean age in group A was 19.79 ± 2.24  years while in group B, it was 20.11 ± 2.53  years. Overall efficacy in adapalene group was 84.2% as compared to 39.6% of tretinoin group (p=0.000).

 

Conclusion  Topical adapalene has a better efficacy than topical tretinoin in the treatment of mild acne vulgaris .

 


Keywords


Acne, adapalene, tretinoin

Full Text:

PDF

References


Ahmad I, Sarwar M. Topical adapalene cream 0.1% versus isotretinoin 0.05% in the treatment of acne vulgaris: a randomized open label clinical trial. J Pak Assoc Dermatol. 2009;19:23-6.

James WD. Acne. N Eng J Med. 2005;352:1463-72.

Orringer JS, Kang S, Hamilyon T, Schumacher W, Cho S, Hammeberg C et al. Treatment of acne vulgaris with a pulsed dye laser: a randomized control trial. JAMA. 2004;291:2834-9.

Kapadia NF, Khalid G, Burhany T, Nahoda T. Comparative efficacy and safety and efficacy of systemic 13-cis retinoic acid 20mg/day vs 40mg/day in acne vulgaris. J Pak Assoc Dermatol. 2005;15:238-41.

James WD. Clinical practice acne. N Eng J Med. 2005;352:1463-72.

Tan HH, Tan WW, Barkham T, Yan XY, Zhu M. Community based study of acne vulgaris in adolescents in Singapore. Br J Dermatol. 2007;157:547-51.

Collier CN, Harper JC, Cafardi JA. The prevalence of acne in adults 20years and older. J Am Acad Dermatol. 2008;58:56-9.

Derno B, Poli F. Epidemiology of acne. Dermatology. 2003;206:7-10.

Amin K, Riddle CC, Aries DJ, Schweiger ES. Common and alternate oral antibiotic therapies for acne vulgaris. J Drugs Dermatol. 2007;6:873-80.

Irby CE, Yentzer BA, Feldman SR. A review of adapalene in the treatment of acne vulgaris. J Adolescent Health. 2008;43:421-4.

Iftikhar U, Aman S, Nadeem M, Kazmi AH. A comparison of efficacy and safety of topical 0.1% adapalene and 4% benzoyl peroxide in the treatment of mild to moderate acne vulgaris. J Pak Assoc Dermatol. 2009;19:141-5.

Campbell JL, Weiss JS. The results of the MORE trial: overview. Cutis. 2006;78:5-11.

Grosshans M, Marks R, Mascaro JM, Torras H, Meynadier J, Alirezai M et al. Evaluation of clinical efficacy and safety of adapalene 0·1% gel versus tretinoin 0·025% gel in the treatment of acne vulgaris, with particular reference to the onset of action and impact on quality of life. Br J Dermatol. 1998;139:26-33.

Thielitz A, Sidou F, Gollnick H. Control of microcomedone formation throughout a maintenance treatment with adapalene gel, 0.1%. J Eur Acad Dermatol Venereol. 2007;21:747-53.


Refbacks

  • There are currently no refbacks.


ISSN: 1560-9014